Skip to content

The Coming Impact of Innovation in Diagnostic Tests and Tools on Alzheimer’s Disease and Dementia Screening, Diagnosis, and Treatment

Advances in the scientific understanding of Alzheimer’s Disease and the emergence of new Alzheimer’s therapies are casting a new light on the future of screening and diagnosis for Alzheimer’s Disease.

Innovative new tests for Alzheimer’s are now emerging or in development, including innovations in cognitive behavioral assessment, imaging, blood-based testing, and other modalities. They will play a major role in shaping the course of screening, diagnosis, and treatment for Alzheimer’s and dementia services in the coming years. 
 
  • This is a hybrid conference with both in-person and virtual participation. View the registration link for more information.
  • The forum is open to the public and will be recorded for viewing on the NEHI website.

Kaiser Permanente Center for Total Health, Convergence Center, 700 2nd Street NE, Washington D.C.

Watch our FULL webinar: 

 

Read our Corresponding Report: Diagnosing Hope: The New Era of Alzheimer’s Disease Treatment Hinges on Innovations in Diagnostics

Tom Hubbard, M.P.P

Tom Hubbard, M.P.P

Senior Vice President of Policy Research, NEHI

Latest Events

Detecting  Dementia: Emerging Innovations and Their Implications for American Adults and Their Health Care

Detecting  Dementia: Emerging Innovations and Their Implications for American Adults and Their Health Care

Leading experts joined Tom Hubbard to discuss emerging innovations for detecting dementia and the implications for clinical practice and he...

The Alzheimer's Disease Patient Journey: Pathways to Early-Stage Screening and Detection

The Alzheimer's Disease Patient Journey: Pathways to Early-Stage Screening and Detection

On May 23, NEHI held a roundtable in Washington on innovative dementia screening tools. Panels discussed their implications for primary car...

Understanding Innovation in Screening and Diagnosis of Alzheimer’s Disease and Related Dementias

Understanding Innovation in Screening and Diagnosis of Alzheimer’s Disease and Related Dementias

Leading experts joined Tom Hubbard to discuss the implications of emerging innovations, including cognitive and functional assessments, bio...